Clinical Trials on Immunocompromised Host
Total 6845 results
-
University of Kansas Medical CenterRecruitingAcute Graft Versus Host DiseaseUnited States
-
CSL BehringNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruitingGraft Versus Host Disease (GVHD)United States
-
Washington University School of MedicineWithdrawnOcular Graft-versus-host DiseaseUnited States
-
Novartis PharmaceuticalsCompletedAcute Graft Versus Host DiseaseBelgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
-
Glia, LLCActive, not recruitingOcular Graft-versus-host DiseaseUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Australia, Canada
-
National Cancer Institute (NCI)Genentech, Inc.TerminatedChronic Graft Versus Host DiseaseUnited States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteGateway for Cancer ResearchCompletedGraft vs. Host DiseaseUnited States
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Ann & Robert H Lurie Children's Hospital of ChicagoDana-Farber Cancer Institute; Fred Hutchinson Cancer Center; University of MinnesotaCompletedGraft vs Host DiseaseUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
ActelionTerminatedChronic Graft Versus Host DiseaseUnited States
-
Stanford UniversityCompletedGraft vs Host DiseaseUnited States
-
Karolinska InstitutetKarolinska University HospitalUnknownGraft vs Host DiseaseSweden
-
Guangdong Provincial People's HospitalSun Yat-sen UniversityUnknownGraft Versus Host DiseaseChina
-
Nantes University HospitalCompleted
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBayer; Genzyme, a Sanofi CompanyCompleted
-
Rabin Medical CenterUnknownGraft Versus Host DiseaseIsrael
-
University Health Network, TorontoHoffmann-La RocheTerminatedGraft Versus Host DiseaseCanada
-
HenogenWithdrawnAcute Graft Versus Host DiseaseNetherlands
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
National Eye Institute (NEI)CompletedGraft-Versus-Host DiseaseUnited States
-
Karolinska InstitutetRegion StockholmWithdrawnGraft -Versus-host-diseaseSweden
-
Ladan EspandarWithdrawnGraft-versus-host DiseaseUnited States
-
MallinckrodtCompletedGraft-versus-Host DiseaseUnited States, Australia, United Kingdom, Slovakia, Brazil, Germany, Italy, Portugal, Turkey
-
Hadassah Medical OrganizationBioIncept LLCUnknown
-
Ohio State University Comprehensive Cancer CenterCompletedGraft-Versus-Host DiseaseUnited States
-
HomeoTherapy Co., LtdCompletedGraft-vs-Host DiseaseKorea, Republic of
-
MedImmune LLCCompletedGraft-Versus-Host DiseaseUnited States
-
IRCCS Burlo GarofoloCompletedAcute Graft-versus-host DiseaseItaly
-
Leland MethenyWithdrawnGastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)United States
-
Seoul National University HospitalTerminatedChronic Graft-versus-host DiseaseKorea, Republic of
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Shenzhen People... and other collaboratorsRecruitingAllogeneic Hematopoietic Stem Cell Transplantation | Acute-graft-versus-host DiseaseChina
-
MaaT PharmaRecruitingAcute Graft Versus Host Disease in Intestine | Steroid Refractory GVHDSpain, France, Germany, Austria, Belgium, Italy
-
Anhui Provincial HospitalRecruitingSteroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)China
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Nanfang Hospital, Southern Medical UniversityShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaNot yet recruitingAcute Graft Versus Host Disease
-
Biotech Pharmaceutical Co., Ltd.Recruiting
-
Peking University People's HospitalRecruiting
-
Mario ArpinatiEuropean CommissionRecruitingChronic Graft Versus Host DiseaseItaly
-
Everett MeyerNational Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Graft Versus Host DiseaseUnited States, Australia, Austria, Canada, China, Croatia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Singapore, Spain, Taiwan
-
Gruppo Italiano Trapianto di Midollo OsseoCompletedChronic Graft Versus Host DiseaseIsrael, Italy
-
John LevineBiogenCompletedAcute Graft Versus Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
Mesoblast, Inc.CompletedGraft Versus Host DiseaseUnited States, Italy, Australia, Canada, Switzerland, United Kingdom